NRCIB
National Research CorporationNASDAQ
1d
5d
1m
6m
1y
5y
10y
Advanced Chart
  • Tue, Nov. 1, 5:10 PM
    • National Research (NASDAQ:NRCIB): Q3 EPS of $0.19 in-line.
    • Revenue of $27.03M (+7.1% Y/Y) misses by $0.03M.
    • Press Release
    | Tue, Nov. 1, 5:10 PM
  • Tue, Aug. 30, 5:03 PM
    • National Research (NASDAQ:NRCIA) declares $0.08/share quarterly dividend, in line with previous.
    • Forward yield 1.99%
    • Payable Oct. 14; for shareholders of record Sept. 30; ex-div Sept. 28.
    | Tue, Aug. 30, 5:03 PM
  • Tue, Aug. 2, 7:02 PM
    • National Research (NASDAQ:NRCIB): Q2 EPS of $0.18 in-line.
    • Revenue of $26.1M (+6.7% Y/Y) misses by $0.1M.
    • Press Release
    | Tue, Aug. 2, 7:02 PM | 1 Comment
  • Tue, May 3, 11:12 PM
    • National Research (NASDAQ:NRCIB): Q1 EPS of $0.21 misses by $0.01.
    • Revenue of $27.9M (+6.2% Y/Y) misses by $0.73M.
    | Tue, May 3, 11:12 PM
  • Tue, Feb. 9, 5:15 PM
    • National Research (NASDAQ:NRCIB): Q4 EPS of $0.24 beats by $0.05.
    • Revenue of $26.4M (+5.2% Y/Y) misses by $0.62M.
    | Tue, Feb. 9, 5:15 PM
  • Dec. 2, 2015, 3:55 PM
    • National Research (NASDAQ:NRCIB) declares $0.48/share quarterly dividend, 33.3% increase from prior dividend of $0.36.
    • Forward yield 5.42%
    • Payable Dec. 15; for shareholders of record Dec. 31; ex-div Dec. 29.
    • Additionally, the board declared special dividend of $2.16/share, payable along with quarterly dividend.
    | Dec. 2, 2015, 3:55 PM
  • Nov. 4, 2015, 8:58 AM
    • National Research (NASDAQ:NRCIB): Q3 EPS of $0.17 in-line.
    • Revenue of $25.24M (+6.6% Y/Y) misses by $0.1M.
    | Nov. 4, 2015, 8:58 AM
  • Aug. 27, 2015, 3:04 PM
    • National Research (NASDAQ:NRCIA) declares $0.06/share quarterly dividend, in line with previous.
    • Forward yield 1.85%
    • Payable Oct. 15; for shareholders of record Sept. 30; ex-div Sept. 28.
    | Aug. 27, 2015, 3:04 PM
  • Aug. 4, 2015, 5:05 PM
    • National Research (NASDAQ:NRCIA): Q2 EPS of $0.16
    • Revenue of $24.46M (+1.9% Y/Y)
    | Aug. 4, 2015, 5:05 PM
  • Feb. 10, 2015, 5:13 PM
    • National Research (NASDAQ:NRCIB): Q4 EPS of $0.17 misses by $0.01.
    • Revenue of $25.1M (+9.5% Y/Y) beats by $0.25M.
    | Feb. 10, 2015, 5:13 PM
  • Nov. 4, 2014, 5:43 PM
    • National Research (NASDAQ:NRCIB): Q3 EPS of $0.19 beats by $0.01.
    • Revenue of $23.68M (+5.7% Y/Y) misses by $0.62M.
    | Nov. 4, 2014, 5:43 PM
  • Nov. 4, 2013, 9:54 AM
    • The B-class stock of National Research Corporation (NRCIB +5.9%) continues a big move following SA Pro's Christopher Owens on Wednesday making the case for their massive undervaluation.
    • Mr. Market has seriously misjudged the potential for National Research to be acquired (which wouldn't be good for the B-class shares), says Owens. Instead, he argues, the new structure was undertaken to allow the CEO to monetize some holdings while maintaining voting control, and for the creation of a non-dilutive acquisition currency (the A-shares).
    • If Owens is right, the B-shares - with voting superiority and entitled to 6x the dividend of the A-class - should trade at 6x the level of the A-shares, making them a potential 3-bagger with limited downside.
    | Nov. 4, 2013, 9:54 AM
  • Aug. 23, 2013, 12:46 PM
    | Aug. 23, 2013, 12:46 PM
  • May 7, 2013, 7:06 PM
    National Research (NRCI): Q1 EPS of $0.64 beats by $0.03. Revenue of $24.9M misses by $0.9M. (PR)
    | May 7, 2013, 7:06 PM
  • Feb. 12, 2013, 6:13 PM
    National Research (NRCI): Q4 EPS of $0.53 misses by $0.03. Revenue of $22M (+15% Y/Y) misses by $0.3M. (PR)
    | Feb. 12, 2013, 6:13 PM
  • Feb. 7, 2013, 9:56 AM
    National Research Corporation (NRCI) declares $0.31/share quarterly dividend, 19% increase from prior dividend of $0.26. Forward yield 2.28%. For shareholders of record Feb. 19. Payable Mar. 29. Ex-div date Feb. 15. (PR)
     
    | Feb. 7, 2013, 9:56 AM